1Batteux F,Toumear L,Trebeden H,et al.Gene therapy of experimental autoimmue thyroiditis by in vivo administration of plasmid DNA coding for Fas ligand[J].J Immunol,1999;162:603.
2Nagata S,Golstein P.The Fas death factor[J].Science,1995;267:1449.
3Hanabushi S,Koyangy M,Kauasaki A,et al.Fas and its ligand in a general mechanism of T-cell mediated cytotoxicity[J].PNAS LSA,1994; 19:4930.
4Stassl G,Todaro M,Bucchievl F,et al.Fas/FasL-driven T cell apotposis as a consequence of ineffective thyroid immunoprivillege in Hashimoto's thyroiditis[J].J Immunol,1999;162:263.
5Hiromatsu Y,Hoshino T,Yagita H,et al.Functional Fas ligand expression in thyrocytes from patients with Graves' disease[J].J Clin Endocrinol Metab,1999; 84:2896.
6Bluher M,Krohn K,Wallaschoski H,et al.Fas and Fas Ligand gene expression in Hashimoto's thyroiditis in BB/W rats[J].European Journal of Endocrinology,1999; 141:506.
7Mitisiades N,Poulaki V,Kotoula V,et al.Fas/FasL ligand up -regulation and Bcl-2 down regulation may be significant in the pathogenesis of Hashimoto's thyroiditis[J].J Clin Endocrinol Metab,1998 ;83(6):2199.
8Bretz JD,Arscott PL,Andrej M,et al.Inflammatory cytokine regulation of Fas-mediated apoposis in thyroid fellicular cells[J].Biol Chem,1999;274:25433.
9Giordano C,Stassi G,De Maria R,Todaro M,et al.Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto 's thyroiditis[J].Sciences,1997; 275:960.
10Kotani T,Artake Y,Hirya K,et al.Apoptosis in thyroid tissue from patients with Hashimoto's thyroiditis[J].Autoimmunity,1995 ;20:231.
